Other Long Term Assets - Dhg Pharmaceutical Joint-Stock Co (VN:DHG) - Alpha Spread
D

Dhg Pharmaceutical Joint-Stock Co
VN:DHG

Watchlist Manager
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Watchlist
Price: 106 500 VND -0.47%
Market Cap: 13.9T VND
Have any thoughts about
Dhg Pharmaceutical Joint-Stock Co?
Write Note

Dhg Pharmaceutical Joint-Stock Co
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dhg Pharmaceutical Joint-Stock Co
Other Long-Term Assets Peer Comparison

Comparables:
H
DHT
I
IMP
C
DCL
D
DMC
T
TRA

Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
D
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Other Long-Term Assets
â‚«77.7B
CAGR 3-Years
36%
CAGR 5-Years
15%
CAGR 10-Years
-3%
H
HaTay Pharmaceutical JSC
VN:DHT
Other Long-Term Assets
â‚«2.2B
CAGR 3-Years
-38%
CAGR 5-Years
-2%
CAGR 10-Years
-4%
I
Imexpharm Corp
VN:IMP
Other Long-Term Assets
â‚«119B
CAGR 3-Years
55%
CAGR 5-Years
34%
CAGR 10-Years
4%
C
Cuu Long Pharmaceutical JSC
VN:DCL
Other Long-Term Assets
â‚«13.2B
CAGR 3-Years
10%
CAGR 5-Years
0%
CAGR 10-Years
N/A
D
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Other Long-Term Assets
â‚«2.1B
CAGR 3-Years
-12%
CAGR 5-Years
-17%
CAGR 10-Years
-17%
T
Traphaco JSC
VN:TRA
Other Long-Term Assets
â‚«60.9B
CAGR 3-Years
1%
CAGR 5-Years
6%
CAGR 10-Years
35%

See Also

What is Dhg Pharmaceutical Joint-Stock Co's Other Long-Term Assets?
Other Long-Term Assets
77.7B VND

Based on the financial report for Jun 30, 2024, Dhg Pharmaceutical Joint-Stock Co's Other Long-Term Assets amounts to 77.7B VND.

What is Dhg Pharmaceutical Joint-Stock Co's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
-3%

Over the last year, the Other Long-Term Assets growth was 36%. The average annual Other Long-Term Assets growth rates for Dhg Pharmaceutical Joint-Stock Co have been 36% over the past three years , 15% over the past five years , and -3% over the past ten years .

Back to Top